PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 112 filers reported holding PULMONX CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $505,447 | -23.1% | 48,931 | -2.4% | 0.00% | 0.0% |
| Q2 2023 | $657,545 | +129849.6% | 50,156 | +10.7% | 0.00% | 0.0% |
| Q1 2023 | $506 | +37.5% | 45,290 | +3.6% | 0.00% | – |
| Q4 2022 | $368 | -99.9% | 43,707 | +3.2% | 0.00% | -100.0% |
| Q3 2022 | $705,000 | +22.0% | 42,343 | +7.9% | 0.00% | 0.0% |
| Q2 2022 | $578,000 | -12.7% | 39,250 | +47.0% | 0.00% | 0.0% |
| Q1 2022 | $662,000 | -17.7% | 26,701 | +6.4% | 0.00% | 0.0% |
| Q4 2021 | $804,000 | -12.7% | 25,084 | -2.0% | 0.00% | 0.0% |
| Q3 2021 | $921,000 | -14.2% | 25,590 | +5.1% | 0.00% | 0.0% |
| Q2 2021 | $1,074,000 | +87.1% | 24,343 | +93.9% | 0.00% | 0.0% |
| Q1 2021 | $574,000 | -28.5% | 12,555 | +7.9% | 0.00% | 0.0% |
| Q4 2020 | $803,000 | – | 11,637 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |